Amphastar Pharmaceuticals Inc (AMPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.44% 183.90	171.17	183.10	191.84	174.41
Cost Of Revenue	10.33% 90.43	100.85	97.44	93.19	87.92
Gross Profit	32.92% 93.47	70.32	85.67	98.65	86.49
Operating Expenses	5.21% 53.74	56.69	50.06	73.33	44.31
Operating Income/Loss	191.48% 39.73	13.63	35.61	25.32	42.18
Nonoperating Income/Loss	66.88% -1.185	-3.578	-3.692	-3.807	-2.849
Income/Loss From Continuing Operations Before Tax	283.45% 38.54	10.05	31.91	21.51	39.34
Income Tax Expense/Benefit	125.66% 8.196	3.632	7.485	4.163	8.305
Net Income/Loss	372.71% 30.35	6.42	24.43	17.35	31.03
Basic Average Shares	3.70% 43.64	45.32	-0.278	46.47	46.95
Diluted Average Shares	4.81% 44.23	46.46	-0.35	47.68	48.13
Basic Earnings Per Share	392.86% 0.69	0.14	0.53	0.38	0.66
Diluted Earnings Per Share	378.57% 0.67	0.14	0.51	0.37	0.64